Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,266,720
-$918,677 QoQ
Shares Held
41,660
-43.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#255
of 754 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $76,467,110 across 63 Biotechnology names. EXEL ranks #3 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,923 | $24,893,587 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
39,811 | $19,775,318 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
41,660 | $2,266,720 | |
| 4 | ARGX |
Argenx SE
|
2,186 | $2,028,105 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
106,632 | $1,995,084 | |
| 6 | INCY |
Incyte Corp
|
15,733 | $1,783,492 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
20,830 | $1,697,853 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
19,611 | $1,534,952 |
All Filings in EXEL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,266,720 | 41,660 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,185,397 | 74,269 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,920,129 | 66,624 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,525,002 | 36,925 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $710,437 | 16,117 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $1,363,271 | 36,925 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $2,379,085 | 71,444 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,018,822 | 39,261 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $618,014 | 27,504 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||